Steven Kao

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

Nico van Zandwijk, Nick Pavlakis, Steven Kao et al. · The Lancet Oncology · 2017 · 681 citations

Dose-escalation Study, Glioma, Medicine +8

Use of chemotherapy at end of life in oncology patients

Steven Kao, Jesmin Shafiq, Janette L. Vardy et al. · Annals of Oncology · 2009 · 156 citations

Palliative Care, Oncology, Oncology Patients +10

Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy

Steven Kao, Sonja Klebe, Douglas W. Henderson et al. · Journal of Thoracic Oncology · 2011 · 91 citations · Full text

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

Aurélien Marabelle, Philippe A. Cassier, Marwan Fakih et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 69 citations · Full text

Medicine, Keynote-158 Study, Pathology +4

Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy

David Levy, Haryana M. Dhillon, Anna J. Lomax et al. · Supportive Care in Cancer · 2018 · 67 citations

Clinical Decision-making, Medicine, Melanoma +4